1. Home
  2. COSM vs ALLR Comparison

COSM vs ALLR Comparison

Compare COSM & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosmos Health Inc.

COSM

Cosmos Health Inc.

HOLD

Current Price

$0.30

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.40

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COSM
ALLR
Founded
2009
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
19.3M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
COSM
ALLR
Price
$0.30
$1.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.75
AVG Volume (30 Days)
982.5K
191.2K
Earning Date
04-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
46.15
N/A
EPS
N/A
N/A
Revenue
$65,271,815.00
$320,000.00
Revenue This Year
$54.08
N/A
Revenue Next Year
$32.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.93
N/A
52 Week Low
$0.28
$0.77
52 Week High
$1.32
$2.35

Technical Indicators

Market Signals
Indicator
COSM
ALLR
Relative Strength Index (RSI) 36.27 51.62
Support Level $0.29 $1.01
Resistance Level $0.41 $1.45
Average True Range (ATR) 0.02 0.13
MACD -0.01 -0.00
Stochastic Oscillator 7.85 34.69

Price Performance

Historical Comparison
COSM
ALLR

About COSM Cosmos Health Inc.

Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: